Continuous glucose monitoring for HIE newborns
Part of Hormones & metabolism clinical trials.
This study tests a continuous glucose monitor (CGM) in newborns with hypoxic-ischemic encephalopathy (HIE) — a type of brain injury from lack of oxygen around birth. The CGM tracks sugar levels to help doctors manage care better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born at 35 weeks or later
- Birth weight over 1.8 kg (about 4 pounds)
- Age under 6 hours now
- Diagnosed with moderate or severe HIE due to lack of oxygen at birth
- No major birth defects, metabolic disorders, or serious infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial uses a continuous glucose monitor (a small sensor placed on the skin) to track blood sugar levels in newborns whose mothers used insulin for gestational diabetes. The goal is to see if this monitoring helps prevent low blood sugar in babies.
This study checks whether a continuous glucose monitor can safely track blood sugar levels in newborns. It may help doctors better understand glucose patterns in babies at birth.
Hear when a new Hypoxic Ischemic Encephalopathy of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.